FERRONE, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 7.956
AS - Asia 3.860
EU - Europa 3.597
SA - Sud America 471
AF - Africa 87
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 4
Totale 15.982
Nazione #
US - Stati Uniti d'America 7.891
SG - Singapore 1.484
CN - Cina 927
SE - Svezia 822
UA - Ucraina 737
IT - Italia 382
BR - Brasile 368
VN - Vietnam 349
HK - Hong Kong 343
FI - Finlandia 332
KR - Corea 303
DE - Germania 281
FR - Francia 263
GB - Regno Unito 142
PL - Polonia 130
TR - Turchia 129
RU - Federazione Russa 127
BG - Bulgaria 111
IE - Irlanda 107
IN - India 70
AR - Argentina 44
MY - Malesia 41
BE - Belgio 33
IQ - Iraq 33
NL - Olanda 33
BD - Bangladesh 32
CH - Svizzera 28
JP - Giappone 26
CA - Canada 25
ZA - Sudafrica 21
MX - Messico 18
EC - Ecuador 16
UZ - Uzbekistan 16
MA - Marocco 15
CZ - Repubblica Ceca 13
KE - Kenya 12
PH - Filippine 12
CO - Colombia 11
PK - Pakistan 11
EG - Egitto 10
ID - Indonesia 9
JO - Giordania 9
VE - Venezuela 9
AT - Austria 8
ES - Italia 8
PY - Paraguay 8
TH - Thailandia 8
DZ - Algeria 7
IL - Israele 7
KZ - Kazakistan 7
CL - Cile 6
EU - Europa 6
LT - Lituania 6
RO - Romania 6
ET - Etiopia 5
HN - Honduras 5
KG - Kirghizistan 5
NP - Nepal 5
AE - Emirati Arabi Uniti 4
PA - Panama 4
PE - Perù 4
SA - Arabia Saudita 4
SN - Senegal 4
TW - Taiwan 4
UY - Uruguay 4
AU - Australia 3
AZ - Azerbaigian 3
GR - Grecia 3
IR - Iran 3
JM - Giamaica 3
LB - Libano 3
NO - Norvegia 3
OM - Oman 3
PT - Portogallo 3
RS - Serbia 3
TN - Tunisia 3
AO - Angola 2
BB - Barbados 2
CI - Costa d'Avorio 2
CY - Cipro 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GA - Gabon 2
GE - Georgia 2
LV - Lettonia 2
MD - Moldavia 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CD - Congo 1
CR - Costa Rica 1
Totale 15.971
Città #
Woodbridge 1.206
Ann Arbor 1.120
Singapore 837
Jacksonville 627
Houston 585
Ashburn 527
Chandler 507
San Jose 403
Fairfield 363
Hong Kong 342
Seoul 301
Hefei 277
Wilmington 273
Beijing 218
Princeton 210
Boardman 184
Seattle 148
Chicago 132
Ho Chi Minh City 113
Cambridge 110
Columbus 110
Sofia 110
Helsinki 108
Dublin 104
Zgierz 103
Lauterbourg 99
Izmir 85
Los Angeles 79
Hanoi 71
Düsseldorf 65
Moscow 62
Munich 59
Buffalo 57
Dearborn 57
The Dalles 52
Frankfurt am Main 43
Falkenstein 42
Dallas 40
Milan 38
San Diego 38
Redwood City 34
São Paulo 34
Bremen 33
Brussels 33
Kocaeli 29
Orem 29
Chennai 28
New York 28
Trieste 26
Santa Clara 25
Bern 23
Tokyo 23
Warsaw 23
Verona 22
Haiphong 19
Shanghai 19
Falls Church 16
Guangzhou 16
Nanjing 16
Amsterdam 15
Des Moines 15
Phoenix 15
Da Nang 14
Redondo Beach 14
Turku 14
Brno 12
Mumbai 12
Tashkent 12
Belo Horizonte 11
London 11
Nairobi 11
Norwalk 11
Casablanca 10
Jinan 10
Quito 10
Rio de Janeiro 10
Tianjin 10
Amman 9
Johannesburg 9
Baghdad 8
Brasília 8
Curitiba 8
Manchester 8
Montreal 8
Rome 8
Biên Hòa 7
Boston 7
Brooklyn 7
Can Tho 7
Cape Town 7
Denver 7
Fremont 7
Grafing 7
Kunming 7
Nanchang 7
Poplar 7
Shenzhen 7
Stockholm 7
Thái Bình 7
Charlotte 6
Totale 10.768
Nome #
Analogies in imatinib-resistant threonine-to-isoleucine mutation in bcr-abl, kit and pdgfra: a combined experimental/computational approach 256
Antifungal and antimycobacterial activity of new N1-[1-aryl-2-(1H-imidazol-1-yl and 1H-1,2,4-triazol-1-yl)-ethylidene]-pyridine-2-carboxamidrazone derivatives: a combined experimental and computational approach 254
Antifungal and antimycobacterial activity of new imidazole and triazole derivatives. A combined experimental and computational approach 254
POLIMERI IN MEDICINA I DENDRIMERI, UN ESEMPIO DI MOLECOLE BIOTECNOLOGICHE 251
Binding at the core. Computational study of structural and ligand binding properties of naphthiridine based dendrimers 248
Synthesis and in vitro evaluation of the anti-viral activity of N-[4-(1H(2H)-benzotriazol-1(2)-yl)phenyl]alkylcarboxamides 220
C-kit mutants in GISTs and their interaction with STI 571: Insights from computer simulations and clinical trials. 217
"Fatty" nucleoside analogs as HCV NS5b inhibitors 215
T670X kit mutations in gastrointestinal stromal tumors: making sense of missense 209
A simple but effective three-dimensional chemical feature-based pharmacophore model for diketo acid derivatives as hepatitis C virus RNA-dependent RNA-polymerase inhibitors 204
Functional analysis and molecular modelling show a preserved wild type activity of p53 C238Y 203
Many-Scale Simulation of ABS/PC Blends for the Automotive Industry 203
A new mutation affecting the ATP pocket of kit receptor in patients with GIST showing acquired resistance to Imatinib: A coupled experimental and modeling investigation 196
Chemical Engineering at the edge of life science. Selected cases of molecular simulations and free-energy calculations for biological and medical applications. 194
Antimycobacterial activity of new 3-substituted 5-(pyridin-4-yl)-3H-1,3,4-oxadiazol-2-one and 2-thione derivatives. Preliminary molecular modelling investigations 189
Synthesis, antifungal and antimycobacterial activities of new bis-imidazole derivatives, and prediction of their binding to P45014DM by molecular docking and MM/PBSA method 188
A new twist for an old song. The DABO story revisited 184
Can computational structural biology be of help in rationalizing clinical data? The Abl/imatinib paradigm 183
Computer simulation of polypropylene/organoclay nanocomposites: characterization of atomic scale structure and prediction of binding energy 181
PET/PEN Blends of Industrial Interest as Barrier Materials. Part I. Many-Scale Molecular Modeling of PET/PEN Blends 180
Synthesis and physico-chemical characterization of folate-cyclodextrin bioconjugate for active drug delivery 178
A cyclodextrin-bioconjugate as carrier for anticancer drugs: from synthesis to molecular modeling 178
Computer Simulation of nylon/organoclay nanocomposites: prediction of the binding energy 175
Can inhibitors of HIV integrase work on HCV polymerase? 175
Design, synthesis and activity of hindered nucleoside analogs with anti-Flaviviridae activity, and their interaction with RdRp 174
Design, synthesis and preliminary in vitro and in silico antiviral activity of [4,7]phenantrolines and 1-oxo-1,4-dihydro-[4,7]phenantrolines against a single-stranded positive sense RNA genome viruses 173
Integrated process of design, synthesis and physicochemical characterization of nanovectors for active drug delivery: the cyclodextrin-folate-bioconjugate example 173
Upgrading polymeric materials from post industrial rejects: a multiscale simulation approach 172
Design, synthesis and characterization of folate-cyclodextrin bioconjugate for active drug delivery: results from combined computational and experimental efforts 172
Diblock copolymers for the automotive industry: the mesoscopic approach 171
Functional analyses and Molecular modeling of two c-Kit mutations responsible for Imatinib secondary resistance in GIST patients 170
Angels and demons of the guardian of the genome. A coupled modeling-biochemical study of p53 mutants in ovarian cancer. 170
Computer simulation of polymer-organoclay nanocomposites for packaging applications: From binding energy to interlayer spacing predictions 167
A talk on the motor side. The free energy for mutating V186 and F244 to Leucine in beta-myosin and its ATP binding 167
A Tumor (GIST), a Mutated Gene (c-kit), and a Molecular Inhibitor (Imatinib): Insights from Computer Simulations 167
Fighting cancer at the nanoscale: computational structural biology and the Bcr-Abl/Imatinib paradigm 166
Grand canonical Monte Carlo simulations for VOCs adsorption in non-polar zeolites 165
Computer-aided simulation of a dendrimer with a protoporphyrinic core as potential, novel hemoprotein mimic. 163
Molecular Simulation of Atrazine Adhesion and Diffusion in a Saturated Sand Model 163
TT315I mutated bcr-abl in chronic myeloid leukemia and imatinib: insights from a computational study 162
Alternative Refrigerants: Thermophysical Properties and Phase equilibra by computational chemistry 162
Delivered to Perfection at Nanoscale. A Coupled Multiscale Simulation/Experimental Investigation of Protein Release from Nanochannel Delivery Systems 161
Chasing the evaders. Design, synthesis, activity and molecular modelling of a new small molecule with activity against drug-resistant HIV-1-mutants 161
Design, synthesis and anti flaviviridae activity of N6-, -O- and 5 O-substituted adenine nucleoside analogs 160
Three-dimensional, nanosized phenylene-based dendrimers: scaling properties studied by a computational approach 158
Studying enzyme enantioselectivity using combined ab initio and free energy calculations: alfa-chymotrypsin and methyl cis- and trans-5-oxo-2-pentylpirrolidine-3-carboxylates 157
New materials from multiscale modelling procedures: properties prediction and customisation of polymeric nanocomposites 157
Nanocompositi: da micro a mesoscala 157
Polymer-Clay Nanocomposites Based on PEO-Diacrylate Macromolecules: a Combined Computational/Experimental Study 156
Genotype-phenotype correlations of myosin mutations: a molecular simulation study 156
Development of an all-atoms force field from ab-initio calculations for alterative refrigerants 154
Computational studies on the enantioselectivity of alpha-chymotrypsin towards beta-carbomethoxy-gamma-lactams. 153
Multiscale modeling of protein transport in silicon membrane nanochannels. Part 1. Derivation of molecular parameters from computer simulations 152
Nano-scaled inorganic/biopolymer composites: Molecular modeling vistas 151
Prediction fo HIV-1 resistance to NNRITs: a computer-aided molecular-based rationale 149
Changes and challenges: GIST, mutated C-KIT and imatinib resistance 149
GCMC Simulations in Zeolite MFI and Activated Carbon for Benzene Removal from Exhaust Gaseous Streams 145
Innovative procedures based on advanced mesoscale simulation techniques for functional polymers in automotive industry 145
Enantiomerically pure beta,gamma-disubstituted gamma-lactams: Enzyme-mediated synthesis and computational studies 144
Release of Proteins from Nanochannel Delivery Systems: a Coupled Many-Scale Simulation - Experimental Investigation 143
Simulation insight on the structure and energetics of biocompatible polymer nanocomposite systems 143
How the Angstrom modifies the nano: effect of point mutations on the nanodimensional structure of human TP53 point mutations 142
Probing the activity of diketoacis as HCV NS5B polymerase inhibitors via detailed molecular modeling 142
Modellazione molecolare e progettazione di nuovi inibitori della serin proteasi NS3 del virus dell’HCV 137
Hydrogen sulphide removal from biogas by zeolite adsorption: part I. GCMC molecular simulations 136
Molecular modeling of Nylon 6/organoclay nanocomposite: prediction of binding energy 134
Of life and Death: Chronic Myeloid Leukemia and the Bcr-Abl/Imatinib Paradigm 134
SYNTHESIS AND ANTI-PICORNAVIRIDAE IN VITRO ACTIVITY OF A NEW CLASS OF HELICASE INHIBITORS THE N,N’-BIS-[4-1H(2H)-BENZOTRIAZOL-1(2)-YL)PHENYL] ALKYLDICARBOXAMIDES. 133
Human TP53 point mutations: structural analysis by molecular modelling 133
PVC/LDPE incompatible blends for industrial applications: A computational multiscale approach 132
Scaling properties in the molecular structure of three-dimensional, nanosized phenylene-based dendrimers as studied by atomistic molecular dynamics simulations 132
Take a walk on the nano side: structural and energetical analysis of ATP-binding pocket mutations of the cardiac beta-myosin heavy chain implicated in familial hypertrophic cardiomyopathy 131
Where are we in HIV research? A novel, computer-based strategy predicting resistance to HIV-1 NNRTIs 130
Shape-persistent polyphenylene-based dendrimers: a computational approach 128
Computational studies of shape-persistent polyphenylene dendrimers 127
Estimation of the binding energy in random poly(butylene terephtalate-co-thiodiethylene terephtalate) copolyesters/clay nanocomposites via molecular simulations 126
Synthesis of a New Series of Nucleoside Analogs with Antiflaviviridae Activity and Their Interaction with RNA-Dependent RNA-Polymerase 126
Using of MM-PBSA in reproducing the binding free energy of NSAIDS to beta-cyclodextrin. 125
Odor emission removal from gaseous streams by the use of zeolites: A molecular simulation approach 125
Enantioselectivity of alpha-chytripsyn towards 4,5-disubstituted-gamma-lactams: a new perspective from molecular simulations 124
Molecular modeling of hydrogen storage in carbon nanotubes: A combined molecular dynamics/ab initio orbital study 123
P53 mutations in sporadic and NF1 related malignant peripheral nerve sheath tumors (MPNST): from clinical evidences to a molecular rationale 122
Hydrogen sulphide removal from biogas by zeolite adsorption: part II. A MD simulation 121
Shape-persistent polyphenylene dendrimers: a computational study 120
Computational alanine scanning to probe DNA - Wild type and mutant p53 interactions. 119
Synthesis, characterization and molecular modeling of a cyclodextrin-bioconjugate as anticancer drug 119
Molecular dynamics and free energy analyses of the interactions between beta-cyclodextrin and some anticancer drugs. 117
Molecular simulation techniques for sustainable technology and environmental applications: general overview and case studies 117
Three-dimensional Pharmacophore Modeling of Hindered Nucleoside Analogs (HNAs) as Inhibitors of the Hepatitis C virus NS5B Polymerase 117
Upgrading block co-polymers from post industrial rejects: a multiscale simulation approach 116
Prediction of thermophysical properties of alternative refrigerants by a novel, ab initio force field 115
Design, synthesis and activity of phosphonoacetic acid (Ppa) ester and amide bioisosters of ribofuranosylnucleoside diphosphates as potential ribonucleotide reductase inhibitors 114
Computer-assisted design of new, potential HCV inhibitors 114
Detailed Molecular Modeling of Point Mutations of P53 113
Host-guest inclusion complexes between anticancer drugs and beta-cytclodextrin: computational studies. 113
Towards Dendrimers as Anticancer Drug Carriers: from in Silico to in Vivo Characterization 111
Diffusion of proteins in nanochannels. A many-scale simulation approach 110
Hindered Nucleoside Analogs (HNA) as Antiflaviviridae Agents 106
Nylon-6/organoclay nanocomposites: prediction of the binding energy by molecular simulation 105
Is tailor-fitting always the best choice? The case of mutations in GISTs and Imatinib 104
Totale 15.636
Categoria #
all - tutte 45.718
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.718


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021386 0 0 0 0 0 0 0 0 0 159 57 170
2021/20221.128 20 100 112 135 13 84 44 41 172 114 52 241
2022/20231.542 141 148 112 207 227 257 13 113 207 16 74 27
2023/2024684 67 48 39 55 86 39 72 154 6 8 43 67
2024/20251.886 41 24 60 199 238 219 126 81 272 206 162 258
2025/20264.457 469 346 342 445 425 498 582 167 617 566 0 0
Totale 16.095